| Goldline Pharmaceutical Ltd |
|
Registered Office:
103 F-1 Leela Apartment Shilpa,HSG Society Shanidham Narendra
,
Nagpur
-
440015
,
Maharashtra
, India.
Phone :
+91 712 278 6666 Fax:
Email : info@goldlinepharma.in
Website : www.goldlinepharma.in
|
Initial public issue of 27,00,000 equity shares of face value of  10/- each ("Equity Shares") of Goldline Pharmaceutical Limited ("Issuer" or "The" "company") at an issue price of 43 per equity share (including a share premium of 33 per equity share) for cash, aggregating to 11.61 Crores ("Public Issue") out of which 1,38,000 equity shares of face value of 10/- each, at an issue price of 43 per equity share for cash, aggregating 0.59 Crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. Issue of 25,62,000 equity shares of face value of 10/- each, at an issue price of 43 per equity share for cash, aggregating up to 11.02 Crores is hereinafter referred to as the "Net Issue". The public issue and net issue will constitute 28.13% and 26.69% respectively of the post-issue paid-up equity share capital of the company.
Price Band is 43 per equity share of face value of 10/- each.
The floor price is 4.3 times of the face value.
Bids can be made for a minimum of Two lot and in multiples of 3,000 equity shares thereafter. |
| Issue |
Money Payable On |
|
| Opens On |
Closes On |
Application |
Allotment |
|
| 12-May-26 |
14-May-26 |
Rs43.00-0.00 |
Rs0.00-0.00 |
| Minimum Application for shares in Nos :6000 Further Multiples of :3000 |
| |
RsCr |
Lead Managers to the Issue |
|
| Project Cost |
10.06 |
| Cumulative Capital Private Limited |
|
| Project Financed through Current Offer |
11.61 |
|
| Post Issue Equity Share Capital |
9.60 |
|
| Issue Price |
Rs43.00 |
|
|